CLX stays a solid hold as brand strength, ERP-driven efficiencies and innovation offset cautious consumers, competition and near-term sales pressure.

Company Announcement Based on the topline results from the EPCORE ® DLBCL-1 trial, Genmab will engage global regulatory authorities to discuss next steps COPENHAGEN, Denmark; January 16, 2026 – Genmab A/S (Nasdaq: GMAB) today announced topline results from the Phase 3 EPCORE DLBCL-1 trial evaluating epcoritamab, a T-cell engaging bispecific antibody administered subcutaneously, which demonstrated an improvement in progression-free survival (PFS) (HR: 0.74 [95% CI 0.60 to 0.92])* in patients treated with epcoritamab monotherapy. Additionally, improvements were observed in the complete response rate, duration of response, and time to next treatment among patients treated with epcoritamab monotherapy.

Bitcoin (BTC-USD) and Silver (SLV) have sharply diverged, setting up a contrarian long BTC, short SLV pair trade opportunity. SLV's recent 150–200% rally appears late-cycle, with realized volatility now exceeding BTC and risk/reward skewed negatively. BTC is gaining regulatory clarity and technical support, while SLV faces risks from margin hikes and substitution at high prices.

Share buyback authorizations, such as the one recently issued by Guidewire Software NYSE: GWRE, are a critical factor for investors, stock prices, and their movement as they reflect managerial confidence in growth and cash flow. Worth $500 million, it is an extension of an earlier program that is now completed.

OUT's diversified ad portfolio, digital billboard push, acquisitions and tech investments are driving growth, backed by industry tailwinds.

Alaska Air heads toward its Jan. 22 Q4 results with EPS estimates slashed, revenues expected to rise 3% and a mixed earnings surprise record.

SERV cuts Gen 3 robot costs sharply, setting the stage for margin improvement as higher utilization and delivery volumes scale across new markets.

American Tower's CoreSite launches native 400G AWS Direct Connect in Chicago to support high-bandwidth workloads and process large data volumes.

Kennametal (KMT) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Southwest Airlines (LUV) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

nLight (LASR) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Boston, Massachusetts--(Newsfile Corp. - January 16, 2026) - Block & Leviton is investigating Travere Therapeutics, Inc. (NASDAQ: TVTX) for potential securities law violations. Investors who have lost money in their Travere Therapeutics, Inc. investment should contact the firm to learn more about how they might recover those losses.

NEW YORK, Jan. 16, 2026 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston announces that a securities class action lawsuit has been filed in the United States District Court for the Northern District of California on behalf of all persons or entities who purchased or otherwise acquired Vistagen Therapeutics, Inc. (“Vistagen” or the “Company”) (NASDAQ: VTGN) securities between April 1, 2024 and December 16, 2025.

PL bets on long-term AI-powered analytics and government deals as heavy investments weigh on near-term profits.

T-Mobile US (TMUS) is regaining investment appeal after underperforming the market and correcting prior overvaluation. TMUS added 2.4 million net customers in the quarter, reaching nearly 140 million and sustaining double-digit YoY growth. The company's 5G broadband business remains small, but its robust spectrum position, aided by the Sprint acquisition, underpins future growth.

NEW YORK, Jan. 16, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of DeFi Technologies, Inc. (NASDAQ: DEFT) between May 12, 2025 and November 14, 2025, both dates inclusive (the "Class Period"), of the important January 30, 2026 lead plaintiff deadline. So What: If you purchased DeFi Technologies securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

PNC Financial delivered strong Q4 results, with EPS of $4.88 and revenue up 9%, driven by Sun Belt expansion and resilient credit quality. PNC's balance sheet showed 3% growth in both deposits and loans, with deposit costs declining and noninterest-bearing balances rebounding. Guidance for 2026 calls for a 14% rise in net interest income and stable credit costs, supporting EPS of $17.85–$18.25 and continued capital returns.

APP's Q3 results show ad-tech scalability at work, with rising revenues and strong EBITDA margins proving growth is now driven by efficiency, not just volume.

CIEN shares are up 42.6% in three months as AI-driven bandwidth demand, a $5B backlog and a raised 2026 outlook fuel the rally despite a premium valuation.

Advanced Micro (AMD) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.